CANDICE VANDERSCHAAF: Open Payments
NPI 1376939652 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,824 in 84 payments from 18 companies in 2025. Trend: 2023 $1,546 · 2024 $1,579 · 2025 $1,824
Food & beverage: $1,587Education: $237
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $351 |
| ABBVIE INC. | 14 | $255 |
| UCB, Inc. | 16 | $227 |
| Regeneron Healthcare Solutions, Inc. | 12 | $202 |
| Janssen Biotech, Inc. | 10 | $194 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $155 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| LEO Pharma Inc. | 2 | $55 |
| Galderma Laboratories, L.P. | 3 | $51 |
| Botanix SB Inc | 2 | $49 |
Products named: DUPIXENT, Bimzelx, TREMFYA, SKYRIZI, RINVOQ, ILUMYA, ADBRY, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
